primary central nervous system lymphoma Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 2 (3)

Interventional (3)

Beijing InnoCare Pharma Tech Co., Ltd. (1)
Memorial Sloan Kettering Cancer Center (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadestimated creatinine clearance

I am/have/hadkidney function tests

I am/have/hadaptt

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadprimary cns lymphoma

I am/have/hadgilbert's syndrome

I am/have/hadblood transfusion

I am/have/hadffpe

I am/have/hadglomerular filtration rate

I am/have/hadplatelet count

I am/have/hadanticoagulants

I am/have/hadct scan

I am/have/hadmeasurable disease

I am/have/hadb-cell lymphoma

I am/have/hadstem cell transplantation

I am/have/hadneutrophil count

I am/have/hadnervous

I am/have/hadplatelet transfusion

I am/have/hadabsolute neutrophil count

I am/have/hadrenal function

added new label for I am/have/had

I am looking for

I am looking forlenalidomide

I am looking fornervous system

I am looking fornivolumab

I am looking formethotrexate

I am looking fordirect bilirubin

I am looking forrituximab

I am looking foranticoagulants

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Rituximab Plus Methotrexate With or Without Lenalidomide in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

It is a multicenter, open-Label, randomised phase 2 study to compare the efficacy and safety study of R2-MTX chemotherapyLenalidomide, Rituximab and Methotrexatewith R-MTX chemotherapyRituximab and Methotrexate as first-line regimens in the treatment of newly diagnosed primary central nervous system lymphoma.2-year Progression free survival (PFS) is the primary endpoint.

estimated creatinine clearance

kidney function tests

nervous system

methotrexate

rituximab

0 views
19 Feb, 2024

Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy

The purpose of this additional part of the study is to test whether the study drug, nivolumab, is a safe treatment that will prevent participants' primary central nervous system lymphoma (PCNSL) from growing again (recurrence). Participants will be people with PCNSL who continue to have cell free tumor DNA (cfDNA) …

gilbert's syndrome

blood transfusion

aptt

nivolumab

neutrophil count

0 views
19 Feb, 2024

A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL

The phase II clinical study is to investigate the safety, tolerability, efficacy and pharmacokinetics of ICP-022.

lymphoma

b-cell lymphoma

diffuse large b-cell lymphoma

primary cns lymphoma

0 views
19 Feb, 2024